Place of innovative therapies in the management of cervical cancer

Bull Cancer. 2023 Dec 11:S0007-4551(23)00429-0. doi: 10.1016/j.bulcan.2023.10.007. Online ahead of print.ABSTRACTDespite optimized screening and prevention strategies, cervical cancer remains a major public health problem, even in developed countries. In France, the incidence is estimated at 3159 cases per year in 2023. While the management of early-stage cases is now highly standardized, few therapeutic advances were made in the treatment of metastatic stages before 2021, before the therapeutic arsenal that we know today took off. The aim of this review is to summarize these advances.PMID:38087730 | DOI:10.1016/j.bulcan.2023.10.007
Source: Bulletin du Cancer - Category: Cancer & Oncology Authors: Source Type: research